ProfileGDS4718 / 238369_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 17% 15% 14% 17% 22% 22% 23% 17% 21% 17% 22% 20% 21% 22% 26% 16% 25% 25% 27% 34% 19% 18% 14% 16% 10% 40% 17% 15% 9% 18% 25% 19% 20% 14% 22% 24% 21% 21% 18% 13% 16% 18% 29% 22% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.0594417
GSM549102patient 115, normal, homogenized [OPG study]3.9900715
GSM549104patient 119, normal, homogenized [OPG study]3.9026514
GSM549108patient 138, normal, homogenized [OPG study]4.0711817
GSM549119patient 077, normal, homogenized [OPG study]4.220722
GSM549133patient 032, cancer, homogenized [OPG study]4.1523122
GSM549139patient 042, cancer, homogenized [OPG study]4.2342723
GSM549099patient 107, normal, homogenized [OPG study]4.0640617
GSM549109patient 139, normal, homogenized [OPG study]4.2089321
GSM549110patient 046, normal, homogenized [OPG study]4.0340917
GSM549114patient 063, normal, homogenized [OPG study]4.1956322
GSM549122patient 082, normal, homogenized [OPG study]4.1352520
GSM549134patient 033, cancer, homogenized [OPG study]4.1663921
GSM549136patient 036, cancer, homogenized [OPG study]4.1497822
GSM549140patient 044, cancer, homogenized [OPG study]4.3498526
GSM549111patient 047, normal, homogenized [OPG study]3.9675516
GSM549113patient 057, normal, homogenized [OPG study]4.2836225
GSM549132patient 031, cancer, homogenized [OPG study]4.3302625
GSM549137patient 038, cancer, homogenized [OPG study]4.392727
GSM549142patient 047, cancer, homogenized [OPG study]4.8101434
GSM549100patient 110, normal, homogenized [OPG study]4.1183519
GSM549107patient 135, normal, homogenized [OPG study]4.0397718
GSM549115patient 068, normal, homogenized [OPG study]3.9041414
GSM549116patient 072, normal, homogenized [OPG study]3.9688916
GSM549120patient 078, normal, homogenized [OPG study]3.7789110
GSM549131patient 030, cancer, homogenized [OPG study]4.9344840
GSM549118patient 074, normal, homogenized [OPG study]4.0383117
GSM549129patient 027, cancer, homogenized [OPG study]3.9732615
GSM549123patient 088, normal, homogenized [OPG study]3.769469
GSM549124patient 006, cancer, homogenized [OPG study]4.1031118
GSM549126patient 015, cancer, homogenized [OPG study]4.3109425
GSM549128patient 025, cancer, homogenized [OPG study]4.0813519
GSM549103patient 117, normal, homogenized [OPG study]4.1882720
GSM549117patient 073, normal, homogenized [OPG study]3.9145114
GSM549138patient 041, cancer, homogenized [OPG study]4.2106222
GSM549141patient 045, cancer, homogenized [OPG study]4.2315424
GSM549130patient 028, cancer, homogenized [OPG study]4.2167521
GSM549101patient 111, normal, homogenized [OPG study]4.1887821
GSM549105patient 128, normal, homogenized [OPG study]4.0815818
GSM549106patient 134, normal, homogenized [OPG study]3.8412113
GSM549112patient 048, normal, homogenized [OPG study]3.9862716
GSM549125patient 011, cancer, homogenized [OPG study]4.0629518
GSM549127patient 024, cancer, homogenized [OPG study]4.4733929
GSM549135patient 035, cancer, homogenized [OPG study]4.1915422